Homelife sciences

life sciences

Journey Medical Corporation Announces Positive Comparative Pharmacokinetic (PK) Data for DFD-29

Journey Medical Corporation Announces Positive Comparative Pharmacokinetic (PK) Data for DFD-29

December 20, 2022

Eyenovia Announces Participation at the 2023 International Consumer Electronics Show

Eyenovia Announces Participation at the 2023 International Consumer Electronics Show

December 20, 2022

BioLineRx Announces Results from Phase 1/2a Study of Investigational Anti-Tumor Vaccine AGI-134 in Metastatic Solid Tumors

BioLineRx Announces Results from Phase 1/2a Study of Investigational Anti-Tumor Vaccine AGI-134 in Metastatic Solid Tumors

December 20, 2022

ContraFect Provides Update from the Futility Analysis of the Phase 3 DISRUPT Study of Exebacase

ContraFect Provides Update from the Futility Analysis of the Phase 3 DISRUPT Study of Exebacase

December 19, 2022

AnPac Bio Reports 48.8% Decrease in Net Loss in First Half of 2022

AnPac Bio Reports 48.8% Decrease in Net Loss in First Half of 2022

December 19, 2022

James Flynn Joins ARCA biopharma Board of Directors

James Flynn Joins ARCA biopharma Board of Directors

December 19, 2022

RM LAW Announces Class Action Lawsuit Against Eiger Biopharmaceuticals, Inc.

RM LAW Announces Class Action Lawsuit Against Eiger Biopharmaceuticals, Inc.

December 19, 2022

Sanofi (SNY) Dupixent Gets CHMP Nod to Eosinophilic Esophagitis

Sanofi (SNY) Dupixent Gets CHMP Nod to Eosinophilic Esophagitis

December 19, 2022

Apellis (APLS) Files MAA for Pegcetacoplan in GA in Europe

Apellis (APLS) Files MAA for Pegcetacoplan in GA in Europe

December 19, 2022

ROSEN, A LEADING NATIONAL FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EIGR

ROSEN, A LEADING NATIONAL FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EIGR

December 19, 2022

« 1 … 7 8 9 10 11 … 557 »